| 1 |
29299985 | VEGF - A Stimulus for Neuronal Development and Regeneration in the CNS and PNS. | 2018 |
2 |
| 2 |
29343861 | Sensing Native Protein Solution Structures Using a Solid-state Nanopore: Unraveling the States of VEGF. | 2018 Jan 17 |
1 |
| 3 |
24210874 | Control of angiogenesis by VEGF and endostatin-encapsulated protein microcrystals and inhibition of tumor angiogenesis. | 2014 Jan |
1 |
| 4 |
26989723 | Vascular endothelial growth factor from embryonic status to cardiovascular pathology. | 2014 Apr |
1 |
| 5 |
23537207 | Design of a cyclotide antagonist of neuropilin-1 and -2 that potently inhibits endothelial cell migration. | 2013 |
1 |
| 6 |
23176598 | High-affinity VEGF antagonists by oligomerization of a minimal sequence VEGF-binding domain. | 2012 Dec 19 |
2 |
| 7 |
22103127 | Biodegradable particulate delivery of vascular endothelial growth factor plasmid from polycaprolactone/polyethylenimine electrospun nanofibers for the treatment of myocardial infarction. | 2011 Aug |
1 |
| 8 |
20068035 | Engineering anti-vascular endothelial growth factor single chain disulfide-stabilized antibody variable fragments (sc-dsFv) with phage-displayed sc-dsFv libraries. | 2010 Mar 12 |
2 |
| 9 |
20308796 | Angiostatin inhibition of vascular endothelial growth factor-stimulated nitric oxide production in endothelial cells. | 2010 |
1 |
| 10 |
20424732 | Signal sequence as a determinant in expressing disulfide-stabilized single chain antibody variable fragments (sc-dsFv) against human VEGF. | 2010 Jul |
3 |
| 11 |
19366703 | Novel vascular endothelial growth factor D variants with increased biological activity. | 2009 Jun 5 |
1 |
| 12 |
19592043 | Immunohistochemical studies of vascular endothelial growth factor in skin of patients with amyotrophic lateral sclerosis. | 2009 Oct 15 |
2 |
| 13 |
16831481 | PEG conjugated VEGF siRNA for anti-angiogenic gene therapy. | 2006 Nov 28 |
2 |
| 14 |
15592500 | Ero1-L alpha plays a key role in a HIF-1-mediated pathway to improve disulfide bond formation and VEGF secretion under hypoxia: implication for cancer. | 2005 Feb 3 |
2 |
| 15 |
21433411 | 86Y-CHX-A''-Diethylenetriamine pentaacetic acid-bevacizumab | 2004 |
1 |
| 16 |
23534080 | 64Cu-1,4,7-Triazacyclononane-1,4,7-triacetic acid-p-isothiocyanatobenzyl-bevacizumab-IRDye 800CW | 2004 |
1 |
| 17 |
23741766 | 68Ga-1,4,7-Triazacyclononane-1,4,7-triacetic acid-p-isothiocyanatobenzyl-vascular endothelial growth factor-121 | 2004 |
1 |
| 18 |
12967471 | Vascular endothelial growth factor receptor-2: its unique signaling and specific ligand, VEGF-E. | 2003 Sep |
2 |
| 19 |
11866530 | Solution structure of a phage-derived peptide antagonist in complex with vascular endothelial growth factor. | 2002 Feb 22 |
1 |
| 20 |
12061718 | Refinement of the solution structure of the heparin-binding domain of vascular endothelial growth factor using residual dipolar couplings. | 2002 May |
1 |
| 21 |
12127077 | Cysteine 116 participates in intermolecular bonding of the human VEGF(121) homodimer. | 2002 Aug 1 |
2 |
| 22 |
12207021 | The cystine knot promotes folding and not thermodynamic stability in vascular endothelial growth factor. | 2002 Nov 8 |
1 |
| 23 |
11106176 | Purification and refolding of vascular endothelial growth factor-B. | 2000 Oct |
1 |
| 24 |
10077638 | Vascular endothelial growth factor (VEGF)-like protein from orf virus NZ2 binds to VEGFR2 and neuropilin-1. | 1999 Mar 16 |
1 |
| 25 |
9922141 | Novel peptides selected to bind vascular endothelial growth factor target the receptor-binding site. | 1998 Dec 22 |
1 |
| 26 |
9244387 | Disulfide structure of the heparin binding domain in vascular endothelial growth factor: characterization of posttranslational modifications in VEGF. | 1997 Aug 1 |
1 |
| 27 |
8637916 | Vascular endothelial growth factor B, a novel growth factor for endothelial cells. | 1996 Mar 19 |
1 |
| 28 |
8841458 | Activation-induced expression of vascular permeability factor by human peripheral T cells: a non-radioisotopic semiquantitative reverse transcription-polymerase chain reaction assay. | 1996 Sep 27 |
4 |
| 29 |
8527160 | Expression of biologically active human vascular endothelial growth factor in yeast. | 1995 |
2 |
| 30 |
7806514 | Covalent dimerization of vascular permeability factor/vascular endothelial growth factor is essential for its biological activity. Evidence from Cys to Ser mutations. | 1994 Dec 30 |
1 |
| 31 |
8264155 | Human mesangial cells and peripheral blood mononuclear cells produce vascular permeability factor. | 1993 Nov |
3 |
| 32 |
1719968 | Effects of a variety of cytokines and inducing agents on vascular permeability factor mRNA levels in U937 cells. | 1991 Oct 31 |
2 |
| 33 |
2584205 | Human vascular permeability factor. Isolation from U937 cells. | 1989 Nov 25 |
1 |
| 34 |
3134521 | Further characterization of malignant glioma-derived vascular permeability factor. | 1988 Aug |
1 |